Sensei Biotherapeutics (SNSE) is scheduled to report Q2 earnings on August 4, 2026. Analysts estimate EPS of $-3.26 and quarterly revenue of N/A.
In the most recent quarter (Q1), Sensei Biotherapeutics reported EPS of $-131.45, missing estimates of $-0.62 by 211.02%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Sensei Biotherapeutics has averaged an EPS surprise of 52.91% and a revenue surprise of 0.00%.
Analyze the earnings history of Sensei Biotherapeutics using advanced sorting and filters.
The chart below shows Sensei Biotherapeutics's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Sensei Biotherapeutics's reported revenue compared to analyst estimates over recent quarters.
Sensei Biotherapeutics (SNSE) is scheduled to report earnings on August 4, 2026. The last reported earnings were for reported on May 15, 2026 for Q1.
The Actual EPS was $-131.45, which missed the estimate of $-0.62.
The Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-15 | $-131.45 | $-0.62 | -21101.6 % |
| Q4 | 2026-03-30 | $-3.74 | $-4.81 | 22.3 % |
| Q3 | 2025-11-14 | $-3.62 | $-4.11 | 11.9 % |
| Q2 | 2025-08-05 | $-3.91 | $-5.48 | 28.6 % |